Details of Host Protein
Host Protein General Information (ID: PT1229) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
Unconventional myosin-VI (MYO6)
|
Gene Name |
MYO6
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
MYO6_HUMAN
|
||||||
Protein Families |
TRAFAC class myosin-kinesin ATPase superfamily
|
||||||||
Subcellular Location |
Cytoplasm and Cytosol; Plasma membrane
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellularmovements. Myosin 6 is a reverse-direction motorprotein that moves towards the minus-end of actin filaments. Has slow rate of actin-activated ADP release due toweak ATP binding. Functions in a variety ofintracellular processes such as vesicular membrane trafficking and cellmigration. Required for the structural integrity of theGolgi apparatus via the p53-dependent pro-survival pathway. Appears to be involved in a very early step ofclathrin-mediated endocytosis in polarized epithelial cells. May act as a regulator of F-actin dynamics. As part of the DISP complex, may regulate the associationof septins with actin and thereby regulate the actin cytoskeleton. May play a role in transporting DAB2 from the plasmamembrane to specific cellular targets. May play a rolein the extension and network organization of neurites. Required for structural integrity of inner ear hair cells. Modulates RNA polymerase II-dependent transcription,
[1-4]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Pathogenic Escherichia coli infection | hsa05130 |
Pathway Map ![]() |
|||||||
Salmonella infection | hsa05132 |
Pathway Map ![]() |
|||||||
Pathogenic Escherichia coli infection | hsa05130 |
Pathway Map ![]() |
|||||||
Salmonella infection | hsa05132 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Function of This Protein During Virus Infection | |||||||||
---|---|---|---|---|---|---|---|---|---|
Virus Name | SARS-COV-2 | Protein Function | Pro-viral | [5] | |||||
Infected Tissue | Lung | Infection Time | 7-9 Days | ||||||
Infected Cell | Calu-3 Cells (Human epithelial cell line) | Cellosaurus ID | CVCL_0609 | ||||||
Method Description | To detect the role of host protein MYO6 in viral infection, MYO6 protein knockout Calu-3 Cells were infected with SARS-COV-2 for 7 - 9 Days , and the effects on infection was detected through CRISPR-based genome-wide gene-knockout screen. | ||||||||
Results | It is reported that knockout of MYO6 leads to the decreased SARS-CoV-2 RNA levels compared with control group. |
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details |
RNA Info
![]() |
[6] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
ORF10
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) |